Breast Cancer Update

Triple-Negative Breast Cancer — Fifth Annual National General Medical Oncology Summit

HR-Positive Metastatic Breast Cancer — A Discussion and Debate on First- and Second-Line Therapy

Desmoid Tumors — Microlearning Activity 3 with Prof Bernd Kasper

Oral SERDs for Breast Cancer — Year in Review Series on Relevant New Datasets and Advances

HR-Positive Metastatic Breast Cancer — An Interview with Dr Seth Wander on Optimizing Biomarker Assessment and Related Treatment Decision-Making

ER-Positive, HER2-Positive Metastatic Breast Cancer — What Clinicians Want to Know About First-Line and Maintenance Therapy

Desmoid Tumors — Microlearning Activity 2 with Dr Ravin Ratan

Diabetology in Breast Cancer — Managing Hyperglycemia in Patients with Breast Cancer Receiving Agents Targeting the PI3K/AKT/PTEN Pathway

Breast Cancer — 5-Minute Journal Club Issue 2 with Dr Lajos Pusztai: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays

Desmoid Tumors — Microlearning Activity 1 with Dr Ravin Ratan

Antibody-Drug Conjugates for Breast Cancer — Year in Review Series on Relevant New Datasets and Advances

Antibody-drug conjugates (ADCs) are transforming the treatment landscape for metastatic breast cancer across HER2-positive, triple-negative, and hormone receptor-positive subtypes. Trastuzumab deruxtecan (TDXD) has established high efficacy in HER2-positive disease, prompting discussions on transitioning to maintenance...

Endocrine-Based Therapy for HR-Positive Breast Cancer — Proceedings from a San Antonio 2025 Symposium Series

HER2-Positive Breast Cancer — Proceedings from a San Antonio 2025 Symposium Series

Antibody-Drug Conjugates for Breast Cancer — Proceedings from a San Antonio 2025 Symposium Series

Toxicities Associated with Antibody-Drug Conjugates for Metastatic Breast Cancer — Clinical Investigator Perspectives on Actual Patient Cases

Breast Cancer — Highlights from the 2025 ESMO Annual Meeting

In this Cancer Conference Update podcast, Dr. Neil Love leads a discussion with Professor Giuseppe Carigliano and Dr. Priyanka Sharma about the key breast cancer papers presented at the 2025 ESMO Annual Meeting in Berlin. The panel reviews practice-changing presentations, focusing on HER2 positive, ER positive, and tri...

Breast Cancer — Microlearning Activity Issue 3 with Dr Priyanka Sharma: 2025 ESMO Annual Meeting Updates

Breast Cancer — Microlearning Activity 2 with Dr Priyanka Sharma: 2025 ESMO Annual Meeting Updates

Metastatic Breast Cancer — Optimizing the Use of Oral Selective Estrogen Receptor Degraders, Part 2

Breast Cancer — Microlearning Activity 1 with Dr Priyanka Sharma: 2025 ESMO Annual Meeting Updates